Showing 24 out of 60 results
2020 Australian IPO Review: Key themes
2020 in review Market conditions in 2020 were of course impacted by the Covid-19 pandemic, but also by record low interest …
Australian IPOs defy early expectations to achieve record end to 2020
The outlook for Australian IPO activity in 2021 is promising following a spate of listings on the ASX in the second half of 2020, according to a new …
Healthcare as an Infrastructure asset
The search for yield is driving infrastructure investors to expand beyond typical core infrastructure assets into core+ or ‘infra-like’ assets. As part …
Hiswara Bunjamin & Tandjung advises PT Omni Healthcare on sale of controlling stake in PT Sarana Meditama Metropolitan Tbk
Leading Indonesian law firm Hiswara Bunjamin & Tandjung (HBT) has advised Indonesian hospital group PT Omni Healthcare on the sale of its controlling …
Deciphering the complex world of underpayment of wages: compliance and enforcement
There have been a number of recent examples of large Australian corporates disclosing that members of their workforce have been underpaid, demonstrating …
Herbert Smith Freehills advises sponsors on Antengene’s HK$2.6 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为德琪医药26亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and JP Morgan as joint sponsors of biopharmaceutical company Antengene …
Herbert Smith Freehills advises Rosemary Health on Series Seed capital raise
Herbert Smith Freehills’ venture capital team has advised Rosemary Health on its Series Seed capital raise.Rosemary Health is telehealth platform that …
Herbert Smith Freehills advises sponsors on Simcere Pharmaceutical’s HK$3.57 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为先声药业35.7亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley Asia Limited and China International Capital Corporation Hong Kong Securities …
The Carry: Private Equity Insights
Herbert Smith Freehills is pleased to announce the second edition of The Carry: Private Equity Insights. In this edition we cover: Key themes …
Digihealth and the dash for data – The key legal issues
As Big Pharma meets Big Tech, demand for health data has exploded. We steer you through the rocky ethical and regulatory terrainThe healthcare and …
Costs of deception – Big fine from Australian watchdog shows need for credible privacy statements
As online booking site HealthEngine faces AUD$2.9m fine, pressure is on businesses to ensure privacy statements have rigourOnline health booking platform …
Herbert Smith Freehills’ finance team advises Crescent Capital Partners on acquisition of PRP Group
Herbert Smith Freehills has advised Crescent Capital Partners on the debt financing aspects of its acquisition of PRP Group. Crescent has been the most …
Showing 24 out of 60 results
View more